tiprankstipranks
Kimberly Clark (KMB)
NASDAQ:KMB
Want to see KMB full AI Analyst Report?

Kimberly Clark (KMB) AI Stock Analysis

4,404 Followers

Top Page

KMB

Kimberly Clark

(NASDAQ:KMB)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 5.2)
Rating:60Neutral
Price Target:
$103.00
â–²(4.21% Upside)
Action:ReiteratedDate:04/28/26
The score is driven primarily by strong cash generation and resilient margins, offset by balance-sheet leverage and declining recent revenue. Valuation is supportive due to a high dividend yield and moderate P/E, while technical signals remain subdued (below key moving averages, negative MACD). Earnings-call messaging was constructive on productivity and share gains, but near-term cost/disruption headwinds and commodity uncertainty temper the outlook.
Positive Factors
Free cash flow generation
Sustained FCF near $2.6B provides durable internal funding for dividends, buybacks, supply‑chain investments and the Kenvue acquisition. Strong cash conversion supports capital allocation flexibility and buffers execution risk over the next 2–6 months.
Negative Factors
Very high leverage
Elevated leverage materially reduces balance‑sheet flexibility and increases financial vulnerability if top‑line or margin pressures persist. High debt amplifies risk around refinancing, limits ability to pace M&A integration spend, and raises interest sensitivity over months.
Read all positive and negative factors
Positive Factors
Negative Factors
Free cash flow generation
Sustained FCF near $2.6B provides durable internal funding for dividends, buybacks, supply‑chain investments and the Kenvue acquisition. Strong cash conversion supports capital allocation flexibility and buffers execution risk over the next 2–6 months.
Read all positive factors

Kimberly Clark (KMB) vs. SPDR S&P 500 ETF (SPY)

Kimberly Clark Business Overview & Revenue Model

Company Description
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care ...
How the Company Makes Money
Kimberly-Clark primarily makes money by manufacturing branded consumer staples and selling them at wholesale prices to retailers and distributors, and directly through certain e-commerce arrangements. Its key revenue streams come from product cate...

Kimberly Clark Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down revenue across different regions, revealing where Kimberly Clark is strongest and where it may face risk or growth potential due to local economic conditions or market share shifts.
Chart InsightsKimberly-Clark's North American revenue shows a steady upward trend, contrasting with a decline in revenue from outside North America. The earnings call highlights challenges such as tariffs and cost pressures impacting profitability. Despite these, the company is optimistic about its Powering Care strategy and product innovations, like Huggies Snug & Dry, which are expected to drive growth. However, organic sales growth in North America is slightly below expectations, influenced by strategic pricing and shipment factors. The focus on SG&A savings and consumer value propositions aims to bolster future performance.
Data provided by:The Fly

Kimberly Clark Earnings Call Summary

Earnings Call Date:Apr 28, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Jul 28, 2026
Earnings Call Sentiment Positive
The call emphasized strong operational execution: sustained organic growth (3% volume+mix), industry-leading productivity (6% gross productivity), share gains across most markets, and active integration planning for the Kenvue combination. Management flagged clear near-term headwinds — a Q2 hit from a California DC fire (~$20M top-line; ~$50M bottom-line in Q2) and potential incremental input costs in H2 of roughly $150–$170M if oil averages ~$100/barrel — but stressed a broad toolkit (pricing net of costs, RGM, productivity, supplier contracting and hedging) and historical ability to recover input-cost inflation. Overall, the positives — market share gains, margin expansion guidance, strong productivity and international growth — were presented as outweighing the identifiable near-term cost uncertainties, though management acknowledged execution risk and timing uncertainty in mitigations.
Positive Updates
Organic Sales and Volume+Mix Growth
Delivered solid organic sales growth in Q1 with volume plus mix increasing to 3%, building on consecutive quarters/years of broad-based growth and reflecting strong base-business momentum.
Negative Updates
Potential Incremental Input Cost Headwind
If oil averages around $100/barrel in the back half, management estimated potential gross incremental input costs of ~$150–$170 million that are not yet built into guidance and remain a moving target.
Read all updates
Q1-2026 Updates
Negative
Organic Sales and Volume+Mix Growth
Delivered solid organic sales growth in Q1 with volume plus mix increasing to 3%, building on consecutive quarters/years of broad-based growth and reflecting strong base-business momentum.
Read all positive updates
Company Guidance
Management maintained its full‑year outlook while flagging near‑term headwinds and the levers it will use to address them: Q1 showed volume‑plus‑mix up 3% (with organic sales growth running about 2.5%), and management raised its rolling‑12‑month category growth outlook to 2.5% (North America cited near ~3.3%); however Q2 will face a ~$20m top‑line hit (≈70–80 bps in North America) from the California DC fire and roughly $50m of incremental operating profit pressure in Q2 from inflation and the fire. If oil averages ~$100/barrel in the back half, management estimated another ~$150–170m of gross input cost exposure (not built into guidance), noting it is ~80% covered across the cost basket via contracts and hedges. Offsets include a very strong productivity pipeline (two prior years of ~6% gross productivity, Q1 already at 6% and a full‑year 6% target), $2bn North America supply‑chain investment, and pricing‑net‑of‑cost discipline; the company said gross margin was down ~60 bps year‑over‑year in Q1 but sequentially improved, operating profit margin expanded ~20 bps this quarter (overhead ~13%, down ~90 bps YoY), and it still expects full‑year gross margin and operating profit margin expansion of roughly 70–80 bps.

Kimberly Clark Financial Statement Overview

Summary
Strong cash generation (TTM FCF ~$2.6B, ~86% of net income) and solid profitability (gross margin ~35–36%, net margin ~11–12%) are positives, but revenue has been declining recently and the balance sheet is a key risk with very high leverage (debt-to-equity ~4.8x) and a limited equity cushion.
Income Statement
62
Positive
Balance Sheet
34
Negative
Cash Flow
72
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue16.54B17.22B20.06B20.43B20.18B19.44B
Gross Profit5.93B6.13B7.18B7.03B6.22B5.99B
EBITDA3.06B3.11B3.98B3.07B3.38B3.25B
Net Income2.12B2.02B2.54B1.76B1.93B1.81B
Balance Sheet
Total Assets17.18B17.23B16.55B17.34B17.97B17.84B
Cash, Cash Equivalents and Short-Term Investments542.00M688.00M1.02B1.09B427.00M270.00M
Total Debt7.08B7.17B7.92B8.11B8.55B8.70B
Total Liabilities15.27B15.57B15.57B16.28B17.27B17.10B
Stockholders Equity1.80B1.50B840.00M915.00M547.00M514.00M
Cash Flow
Free Cash Flow2.58B1.64B2.51B2.78B1.86B1.72B
Operating Cash Flow3.19B2.78B3.23B3.54B2.73B2.73B
Investing Cash Flow-3.23B-951.00M-100.00M-418.00M-785.00M-1.06B
Financing Cash Flow15.00M-2.18B-3.17B-2.37B-1.76B-1.70B

Kimberly Clark Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price98.84
Price Trends
50DMA
101.67
Negative
100DMA
101.00
Negative
200DMA
110.47
Negative
Market Momentum
MACD
-0.92
Negative
RSI
51.12
Neutral
STOCH
79.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KMB, the sentiment is Neutral. The current price of 98.84 is above the 20-day moving average (MA) of 97.48, below the 50-day MA of 101.67, and below the 200-day MA of 110.47, indicating a neutral trend. The MACD of -0.92 indicates Negative momentum. The RSI at 51.12 is Neutral, neither overbought nor oversold. The STOCH value of 79.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for KMB.

Kimberly Clark Risk Analysis

Kimberly Clark disclosed 26 risk factors in its most recent earnings report. Kimberly Clark reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Kimberly Clark Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$333.97B21.9931.28%2.92%3.33%8.06%
69
Neutral
$130.27B11.8526.01%3.74%-13.78%11.80%
65
Neutral
$22.01B25.5117.45%1.38%2.22%29.40%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
$31.75B12.04143.64%5.03%-16.17%-13.40%
60
Neutral
$68.31B26.46475.13%2.67%4.26%-27.12%
53
Neutral
$10.46B16.812826.17%5.05%-3.69%10.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KMB
Kimberly Clark
95.65
-32.25
-25.22%
CHD
Church & Dwight
92.89
2.08
2.29%
CLX
Clorox
86.48
-44.11
-33.78%
CL
Colgate-Palmolive
85.37
-3.27
-3.69%
PG
Procter & Gamble
143.42
-11.42
-7.37%
UL
Unilever
58.71
-7.74
-11.65%

Kimberly Clark Corporate Events

Business Operations and StrategyM&A TransactionsShareholder Meetings
Kimberly-Clark Shareholders Approve Kenvue Acquisition Plan
Positive
Jan 29, 2026
At virtual special meetings on January 29, 2026, Kimberly-Clark and Kenvue shareholders overwhelmingly approved the stock issuance and merger agreement underlying Kimberly-Clark’s planned acquisition of Kenvue, with 96% of K-C votes cast bac...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 28, 2026